Antibodies
21 March 2014
FDA Approves Xolair® (omalizumab) for People with Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives21 March 2014
AVEO Regains Worldwide Rights to AV-20318 March 2014
Igenica Biotherapeutics Enrolls First Patient in Phase 1 Study of IGN523 in Acute Myeloid Leukemia17 March 2014
Resolve Initiates RSLV-132 Clinical Studies17 March 2014
Amorfix and Trellis Bioscience to collaborate on anti-CD38 antibody treatment for cancer13 March 2014
GSK announces positive results from phase III studies for mepolizumab in severe eosinophilic asthma5 March 2014
New Published Paper Shows Efficacy of Lpath’s Anti-LPA Antibody, Lpathomab, in Traumatic Brain Injury ModelsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports